Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody-drug conjugates
Pharma
GSK's ADC Blenrep delivers survival win against J&J's Darzalex
The head-to-head overall survival win makes GSK’s £3 billion peak sales goal for the multiple myeloma antibody-drug conjugate look more attainable.
Angus Liu
Nov 14, 2024 9:24am
Daiichi enlists Alteogen for subcutaneous Enhertu in $300M deal
Nov 8, 2024 11:19am
Gilead pulls Trodelvy in bladder cancer after trial flop
Oct 18, 2024 10:18am
AstraZeneca-CSPC, Astellas and more—Fierce Pharma Asia
Oct 11, 2024 9:48am
Daiichi, Fosun, Yuhan and more—Fierce Pharma Asia
Sep 27, 2024 10:15am
Daiichi, Eisai, Granules—Fierce Pharma Asia
Sep 20, 2024 10:16am
